APO Research
Talk to an analyst

APO RESEARCH · REPORT

Friedreich Ataxia Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Friedreich Ataxia Drug Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchFriedreich Ataxia Drug Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Friedreich Ataxia Drug Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Friedreich Ataxia Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Friedreich Ataxia Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Friedreich Ataxia Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Friedreich Ataxia Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Friedreich Ataxia Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Friedreich Ataxia Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Friedreich Ataxia Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Friedreich Ataxia Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Friedreich Ataxia Drug include Takeda, Pfizer Inc, Voyager Therapeutics Inc, STATegics Inc, Retrotope Inc, Reata Pharmaceuticals Inc, RaNA Therapeutics Inc, ProQR Therapeutics NV and Ixchel Pharma LLC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Friedreich Ataxia Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Friedreich Ataxia Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Friedreich Ataxia Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Friedreich Ataxia Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Friedreich Ataxia Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Friedreich Ataxia Drug sales, projected growth trends, production technology, application and end-user industry.

Friedreich Ataxia Drug Segment by Company

Takeda

Pfizer Inc

Voyager Therapeutics Inc

STATegics Inc

Retrotope Inc

Reata Pharmaceuticals Inc

RaNA Therapeutics Inc

ProQR Therapeutics NV

Ixchel Pharma LLC

Forward Pharma A/S

Catabasis Pharmaceuticals, Inc.

Cardero Therapeutics Inc

Biovista Inc.

BioMarin Pharmaceutical Inc.

Adverum Biotechnologies Inc

Friedreich Ataxia Drug Segment by Type

BVA-202

BHV-4157

AGIL-FA

ADVM-063

Others

Friedreich Ataxia Drug Segment by Application

Clinic

Hospital

Others

Friedreich Ataxia Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Friedreich Ataxia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Friedreich Ataxia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Friedreich Ataxia Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Friedreich Ataxia Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Friedreich Ataxia Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Friedreich Ataxia Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Friedreich Ataxia Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BVA-202 Major Manufacturers Table 3. BHV-4157 Major Manufacturers Table 4. AGIL-FA Major Manufacturers Table 5. ADVM-063 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Friedreich Ataxia Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Others Major Manufacturers Table 11. Friedreich Ataxia Drug Industry Trends Table 12. Friedreich Ataxia Drug Industry Drivers Table 13. Friedreich Ataxia Drug Industry Opportunities and Challenges Table 14. Friedreich Ataxia Drug Industry Restraints Table 15. Global Friedreich Ataxia Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Friedreich Ataxia Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Friedreich Ataxia Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Friedreich Ataxia Drug Revenue Market Share by Region (2021-2026) Table 19. Global Friedreich Ataxia Drug Revenue Market Share by Region (2027-2032) Table 20. Global Friedreich Ataxia Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Friedreich Ataxia Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Friedreich Ataxia Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Friedreich Ataxia Drug Sales Market Share by Region (2021-2026) Table 24. Global Friedreich Ataxia Drug Sales Market Share by Region (2027-2032) Table 25. Global Friedreich Ataxia Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Friedreich Ataxia Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Friedreich Ataxia Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Friedreich Ataxia Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Friedreich Ataxia Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Friedreich Ataxia Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Friedreich Ataxia Drug Manufacturers, Product Type & Application Table 33. Global Friedreich Ataxia Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Friedreich Ataxia Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Friedreich Ataxia Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Friedreich Ataxia Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Friedreich Ataxia Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Friedreich Ataxia Drug Revenue Market Share by Type (2021-2026) Table 40. Global Friedreich Ataxia Drug Revenue Market Share by Type (2027-2032) Table 41. Global Friedreich Ataxia Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Friedreich Ataxia Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Friedreich Ataxia Drug Sales Market Share by Type (2021-2026) Table 45. Global Friedreich Ataxia Drug Sales Market Share by Type (2027-2032) Table 46. Global Friedreich Ataxia Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Friedreich Ataxia Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Friedreich Ataxia Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Friedreich Ataxia Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Friedreich Ataxia Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Friedreich Ataxia Drug Revenue Market Share by Application (2021-2026) Table 52. Global Friedreich Ataxia Drug Revenue Market Share by Application (2027-2032) Table 53. Global Friedreich Ataxia Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Friedreich Ataxia Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Friedreich Ataxia Drug Sales Market Share by Application (2021-2026) Table 57. Global Friedreich Ataxia Drug Sales Market Share by Application (2027-2032) Table 58. Global Friedreich Ataxia Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Friedreich Ataxia Drug Price by Application (2027-2032) & (US$/Unit) Table 60. Takeda Company Information Table 61. Takeda Business Overview Table 62. Takeda Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Takeda Friedreich Ataxia Drug Product Portfolio Table 64. Takeda Recent Development Table 65. Pfizer Inc Company Information Table 66. Pfizer Inc Business Overview Table 67. Pfizer Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Pfizer Inc Friedreich Ataxia Drug Product Portfolio Table 69. Pfizer Inc Recent Development Table 70. Voyager Therapeutics Inc Company Information Table 71. Voyager Therapeutics Inc Business Overview Table 72. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Voyager Therapeutics Inc Friedreich Ataxia Drug Product Portfolio Table 74. Voyager Therapeutics Inc Recent Development Table 75. STATegics Inc Company Information Table 76. STATegics Inc Business Overview Table 77. STATegics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. STATegics Inc Friedreich Ataxia Drug Product Portfolio Table 79. STATegics Inc Recent Development Table 80. Retrotope Inc Company Information Table 81. Retrotope Inc Business Overview Table 82. Retrotope Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Retrotope Inc Friedreich Ataxia Drug Product Portfolio Table 84. Retrotope Inc Recent Development Table 85. Reata Pharmaceuticals Inc Company Information Table 86. Reata Pharmaceuticals Inc Business Overview Table 87. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Portfolio Table 89. Reata Pharmaceuticals Inc Recent Development Table 90. RaNA Therapeutics Inc Company Information Table 91. RaNA Therapeutics Inc Business Overview Table 92. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. RaNA Therapeutics Inc Friedreich Ataxia Drug Product Portfolio Table 94. RaNA Therapeutics Inc Recent Development Table 95. ProQR Therapeutics NV Company Information Table 96. ProQR Therapeutics NV Business Overview Table 97. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. ProQR Therapeutics NV Friedreich Ataxia Drug Product Portfolio Table 99. ProQR Therapeutics NV Recent Development Table 100. Ixchel Pharma LLC Company Information Table 101. Ixchel Pharma LLC Business Overview Table 102. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Ixchel Pharma LLC Friedreich Ataxia Drug Product Portfolio Table 104. Ixchel Pharma LLC Recent Development Table 105. Forward Pharma A/S Company Information Table 106. Forward Pharma A/S Business Overview Table 107. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Forward Pharma A/S Friedreich Ataxia Drug Product Portfolio Table 109. Forward Pharma A/S Recent Development Table 110. Catabasis Pharmaceuticals, Inc. Company Information Table 111. Catabasis Pharmaceuticals, Inc. Business Overview Table 112. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Portfolio Table 114. Catabasis Pharmaceuticals, Inc. Recent Development Table 115. Cardero Therapeutics Inc Company Information Table 116. Cardero Therapeutics Inc Business Overview Table 117. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Cardero Therapeutics Inc Friedreich Ataxia Drug Product Portfolio Table 119. Cardero Therapeutics Inc Recent Development Table 120. Biovista Inc. Company Information Table 121. Biovista Inc. Business Overview Table 122. Biovista Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Biovista Inc. Friedreich Ataxia Drug Product Portfolio Table 124. Biovista Inc. Recent Development Table 125. BioMarin Pharmaceutical Inc. Company Information Table 126. BioMarin Pharmaceutical Inc. Business Overview Table 127. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Portfolio Table 129. BioMarin Pharmaceutical Inc. Recent Development Table 130. Adverum Biotechnologies Inc Company Information Table 131. Adverum Biotechnologies Inc Business Overview Table 132. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Portfolio Table 134. Adverum Biotechnologies Inc Recent Development Table 135. North America Friedreich Ataxia Drug Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Friedreich Ataxia Drug Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Units) Table 138. North America Friedreich Ataxia Drug Sales by Type (2027-2032) & (K Units) Table 139. North America Friedreich Ataxia Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 140. North America Friedreich Ataxia Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 141. North America Friedreich Ataxia Drug Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Friedreich Ataxia Drug Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Units) Table 144. North America Friedreich Ataxia Drug Sales by Application (2027-2032) & (K Units) Table 145. North America Friedreich Ataxia Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 146. North America Friedreich Ataxia Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 147. North America Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Friedreich Ataxia Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Friedreich Ataxia Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. North America Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Units) Table 152. North America Friedreich Ataxia Drug Sales by Country (2027-2032) & (K Units) Table 153. North America Friedreich Ataxia Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 154. North America Friedreich Ataxia Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 155. United States Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 156. Canada Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 157. Europe Friedreich Ataxia Drug Revenue by Type (2021-2026) & (US$ Million) Table 158. Europe Friedreich Ataxia Drug Revenue by Type (2027-2032) & (US$ Million) Table 159. Europe Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Units) Table 160. Europe Friedreich Ataxia Drug Sales by Type (2027-2032) & (K Units) Table 161. Europe Friedreich Ataxia Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Europe Friedreich Ataxia Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Europe Friedreich Ataxia Drug Revenue by Application (2021-2026) & (US$ Million) Table 164. Europe Friedreich Ataxia Drug Revenue by Application (2027-2032) & (US$ Million) Table 165. Europe Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Units) Table 166. Europe Friedreich Ataxia Drug Sales by Application (2027-2032) & (K Units) Table 167. Europe Friedreich Ataxia Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Europe Friedreich Ataxia Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Europe Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Friedreich Ataxia Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Europe Friedreich Ataxia Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Europe Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Europe Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Units) Table 174. Europe Friedreich Ataxia Drug Sales by Country (2027-2032) & (K Units) Table 175. Europe Friedreich Ataxia Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Europe Friedreich Ataxia Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Germany Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 178. France Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 179. U.K. Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 180. Italy Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 182. China Friedreich Ataxia Drug Revenue by Type (2021-2026) & (US$ Million) Table 183. China Friedreich Ataxia Drug Revenue by Type (2027-2032) & (US$ Million) Table 184. China Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Units) Table 185. China Friedreich Ataxia Drug Sales by Type (2027-2032) & (K Units) Table 186. China Friedreich Ataxia Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 187. China Friedreich Ataxia Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 188. China Friedreich Ataxia Drug Revenue by Application (2021-2026) & (US$ Million) Table 189. China Friedreich Ataxia Drug Revenue by Application (2027-2032) & (US$ Million) Table 190. China Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Units) Table 191. China Friedreich Ataxia Drug Sales by Application (2027-2032) & (K Units) Table 192. China Friedreich Ataxia Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 193. China Friedreich Ataxia Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Friedreich Ataxia Drug Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Friedreich Ataxia Drug Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Units) Table 197. Asia Friedreich Ataxia Drug Sales by Type (2027-2032) & (K Units) Table 198. Asia Friedreich Ataxia Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Asia Friedreich Ataxia Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Asia Friedreich Ataxia Drug Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Friedreich Ataxia Drug Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Units) Table 203. Asia Friedreich Ataxia Drug Sales by Application (2027-2032) & (K Units) Table 204. Asia Friedreich Ataxia Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Asia Friedreich Ataxia Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Friedreich Ataxia Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Friedreich Ataxia Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. Asia Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Units) Table 211. Asia Friedreich Ataxia Drug Sales by Country (2027-2032) & (K Units) Table 212. Asia Friedreich Ataxia Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Asia Friedreich Ataxia Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Japan Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 215. South Korea Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 216. India Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 217. Australia Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 218. China Taiwan Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Friedreich Ataxia Drug Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Friedreich Ataxia Drug Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Friedreich Ataxia Drug Sales by Type (2021-2026) & (K Units) Table 223. SAMEA Friedreich Ataxia Drug Sales by Type (2027-2032) & (K Units) Table 224. SAMEA Friedreich Ataxia Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 225. SAMEA Friedreich Ataxia Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 226. SAMEA Friedreich Ataxia Drug Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Friedreich Ataxia Drug Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Friedreich Ataxia Drug Sales by Application (2021-2026) & (K Units) Table 229. SAMEA Friedreich Ataxia Drug Sales by Application (2027-2032) & (K Units) Table 230. SAMEA Friedreich Ataxia Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 231. SAMEA Friedreich Ataxia Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 232. SAMEA Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Friedreich Ataxia Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Friedreich Ataxia Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. SAMEA Friedreich Ataxia Drug Sales by Country (2021-2026) & (K Units) Table 237. SAMEA Friedreich Ataxia Drug Sales by Country (2027-2032) & (K Units) Table 238. SAMEA Friedreich Ataxia Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 239. SAMEA Friedreich Ataxia Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Brazil Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 241. Argentina Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 242. Chile Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 243. Colombia Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 244. Peru Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 246. Israel Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 247. UAE Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 248. Turkey Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 249. Iran Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 250. Egypt Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Friedreich Ataxia Drug Distributors List Table 254. Friedreich Ataxia Drug Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Friedreich Ataxia Drug Image Figure 2. Global Friedreich Ataxia Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Friedreich Ataxia Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. BVA-202 Image Figure 5. BHV-4157 Image Figure 6. AGIL-FA Image Figure 7. ADVM-063 Image Figure 8. Others Image Figure 9. Global Friedreich Ataxia Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Friedreich Ataxia Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Others Image Figure 14. Global Friedreich Ataxia Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Friedreich Ataxia Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Friedreich Ataxia Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Friedreich Ataxia Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Friedreich Ataxia Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Friedreich Ataxia Drug Sales (2021-2032) & (K Units) Figure 20. Global Friedreich Ataxia Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Friedreich Ataxia Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Friedreich Ataxia Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Friedreich Ataxia Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Friedreich Ataxia Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Friedreich Ataxia Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Friedreich Ataxia Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Friedreich Ataxia Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Friedreich Ataxia Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Friedreich Ataxia Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Friedreich Ataxia Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Friedreich Ataxia Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Friedreich Ataxia Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Friedreich Ataxia Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Friedreich Ataxia Drug Sales Market Share by Type (2021-2032) Figure 36. Global Friedreich Ataxia Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Friedreich Ataxia Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Friedreich Ataxia Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Friedreich Ataxia Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Friedreich Ataxia Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Friedreich Ataxia Drug Sales Market Share by Application (2021-2032) Figure 42. North America Friedreich Ataxia Drug Revenue Share by Type (2021-2032) Figure 43. North America Friedreich Ataxia Drug Sales Share by Type (2021-2032) Figure 44. North America Friedreich Ataxia Drug Revenue Share by Application (2021-2032) Figure 45. North America Friedreich Ataxia Drug Sales Share by Application (2021-2032) Figure 46. North America Friedreich Ataxia Drug Revenue Share by Country (2021-2032) Figure 47. North America Friedreich Ataxia Drug Sales Share by Country (2021-2032) Figure 48. Europe Friedreich Ataxia Drug Revenue Share by Type (2021-2032) Figure 49. Europe Friedreich Ataxia Drug Sales Share by Type (2021-2032) Figure 50. Europe Friedreich Ataxia Drug Revenue Share by Application (2021-2032) Figure 51. Europe Friedreich Ataxia Drug Sales Share by Application (2021-2032) Figure 52. Europe Friedreich Ataxia Drug Revenue Share by Country (2021-2032) Figure 53. Europe Friedreich Ataxia Drug Sales Share by Country (2021-2032) Figure 54. China Friedreich Ataxia Drug Revenue Share by Type (2021-2032) Figure 55. China Friedreich Ataxia Drug Sales Share by Type (2021-2032) Figure 56. China Friedreich Ataxia Drug Revenue Share by Application (2021-2032) Figure 57. China Friedreich Ataxia Drug Sales Share by Application (2021-2032) Figure 58. Asia Friedreich Ataxia Drug Revenue Share by Type (2021-2032) Figure 59. Asia Friedreich Ataxia Drug Sales Share by Type (2021-2032) Figure 60. Asia Friedreich Ataxia Drug Revenue Share by Application (2021-2032) Figure 61. Asia Friedreich Ataxia Drug Sales Share by Application (2021-2032) Figure 62. Asia Friedreich Ataxia Drug Revenue Share by Country (2021-2032) Figure 63. Asia Friedreich Ataxia Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Friedreich Ataxia Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Friedreich Ataxia Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Friedreich Ataxia Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Friedreich Ataxia Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Friedreich Ataxia Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Friedreich Ataxia Drug Sales Share by Country (2021-2032) Figure 70. Friedreich Ataxia Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Friedreich Ataxia Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • BVA-202
  • BHV-4157
  • AGIL-FA
  • ADVM-063
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Takeda
  • Pfizer Inc
  • Voyager Therapeutics Inc
  • STATegics Inc
  • Retrotope Inc
  • Reata Pharmaceuticals Inc
  • RaNA Therapeutics Inc
  • ProQR Therapeutics NV
  • Ixchel Pharma LLC
  • Forward Pharma A/S
  • Catabasis Pharmaceuticals, Inc.
  • Cardero Therapeutics Inc
  • Biovista Inc.
  • BioMarin Pharmaceutical Inc.
  • Adverum Biotechnologies Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Friedreich Ataxia Drug Market by Type
  3. 1.2.1 Global Friedreich Ataxia Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BVA-202
  5. 1.2.3 BHV-4157
  6. 1.2.4 AGIL-FA
  7. 1.2.5 ADVM-063
  8. 1.2.6 Others
  9. 1.3 Friedreich Ataxia Drug Market by Application
  10. 1.3.1 Global Friedreich Ataxia Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Friedreich Ataxia Drug Market Dynamics
  1. 2.1 Friedreich Ataxia Drug Industry Trends
  2. 2.2 Friedreich Ataxia Drug Industry Drivers
  3. 2.3 Friedreich Ataxia Drug Industry Opportunities and Challenges
  4. 2.4 Friedreich Ataxia Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Friedreich Ataxia Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Friedreich Ataxia Drug Revenue by Region
  3. 3.2.1 Global Friedreich Ataxia Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Friedreich Ataxia Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Friedreich Ataxia Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Friedreich Ataxia Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Friedreich Ataxia Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Friedreich Ataxia Drug Sales by Region
  9. 3.4.1 Global Friedreich Ataxia Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Friedreich Ataxia Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Friedreich Ataxia Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Friedreich Ataxia Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Friedreich Ataxia Drug Revenue by Manufacturers
  2. 4.1.1 Global Friedreich Ataxia Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Friedreich Ataxia Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Friedreich Ataxia Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Friedreich Ataxia Drug Sales by Manufacturers
  6. 4.2.1 Global Friedreich Ataxia Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Friedreich Ataxia Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Friedreich Ataxia Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Friedreich Ataxia Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Friedreich Ataxia Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Friedreich Ataxia Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Friedreich Ataxia Drug Manufacturers, Product Type & Application
  13. 4.7 Global Friedreich Ataxia Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Friedreich Ataxia Drug Market CR5 and HHI
  16. 4.8.2 2025 Friedreich Ataxia Drug Tier 1, Tier 2, and Tier 3
5 Friedreich Ataxia Drug Market by Type
  1. 5.1 Global Friedreich Ataxia Drug Revenue by Type
  2. 5.1.1 Global Friedreich Ataxia Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Friedreich Ataxia Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Friedreich Ataxia Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Friedreich Ataxia Drug Sales by Type
  6. 5.2.1 Global Friedreich Ataxia Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Friedreich Ataxia Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Friedreich Ataxia Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Friedreich Ataxia Drug Price by Type
6 Friedreich Ataxia Drug Market by Application
  1. 6.1 Global Friedreich Ataxia Drug Revenue by Application
  2. 6.1.1 Global Friedreich Ataxia Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Friedreich Ataxia Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Friedreich Ataxia Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Friedreich Ataxia Drug Sales by Application
  6. 6.2.1 Global Friedreich Ataxia Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Friedreich Ataxia Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Friedreich Ataxia Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Friedreich Ataxia Drug Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Friedreich Ataxia Drug Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Pfizer Inc
  8. 7.2.1 Pfizer Inc Company Information
  9. 7.2.2 Pfizer Inc Business Overview
  10. 7.2.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc Friedreich Ataxia Drug Product Portfolio
  12. 7.2.5 Pfizer Inc Recent Developments
  13. 7.3 Voyager Therapeutics Inc
  14. 7.3.1 Voyager Therapeutics Inc Company Information
  15. 7.3.2 Voyager Therapeutics Inc Business Overview
  16. 7.3.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
  18. 7.3.5 Voyager Therapeutics Inc Recent Developments
  19. 7.4 STATegics Inc
  20. 7.4.1 STATegics Inc Company Information
  21. 7.4.2 STATegics Inc Business Overview
  22. 7.4.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 STATegics Inc Friedreich Ataxia Drug Product Portfolio
  24. 7.4.5 STATegics Inc Recent Developments
  25. 7.5 Retrotope Inc
  26. 7.5.1 Retrotope Inc Company Information
  27. 7.5.2 Retrotope Inc Business Overview
  28. 7.5.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Retrotope Inc Friedreich Ataxia Drug Product Portfolio
  30. 7.5.5 Retrotope Inc Recent Developments
  31. 7.6 Reata Pharmaceuticals Inc
  32. 7.6.1 Reata Pharmaceuticals Inc Company Information
  33. 7.6.2 Reata Pharmaceuticals Inc Business Overview
  34. 7.6.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Portfolio
  36. 7.6.5 Reata Pharmaceuticals Inc Recent Developments
  37. 7.7 RaNA Therapeutics Inc
  38. 7.7.1 RaNA Therapeutics Inc Company Information
  39. 7.7.2 RaNA Therapeutics Inc Business Overview
  40. 7.7.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
  42. 7.7.5 RaNA Therapeutics Inc Recent Developments
  43. 7.8 ProQR Therapeutics NV
  44. 7.8.1 ProQR Therapeutics NV Company Information
  45. 7.8.2 ProQR Therapeutics NV Business Overview
  46. 7.8.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 ProQR Therapeutics NV Friedreich Ataxia Drug Product Portfolio
  48. 7.8.5 ProQR Therapeutics NV Recent Developments
  49. 7.9 Ixchel Pharma LLC
  50. 7.9.1 Ixchel Pharma LLC Company Information
  51. 7.9.2 Ixchel Pharma LLC Business Overview
  52. 7.9.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Ixchel Pharma LLC Friedreich Ataxia Drug Product Portfolio
  54. 7.9.5 Ixchel Pharma LLC Recent Developments
  55. 7.10 Forward Pharma A/S
  56. 7.10.1 Forward Pharma A/S Company Information
  57. 7.10.2 Forward Pharma A/S Business Overview
  58. 7.10.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Forward Pharma A/S Friedreich Ataxia Drug Product Portfolio
  60. 7.10.5 Forward Pharma A/S Recent Developments
  61. 7.11 Catabasis Pharmaceuticals, Inc.
  62. 7.11.1 Catabasis Pharmaceuticals, Inc. Company Information
  63. 7.11.2 Catabasis Pharmaceuticals, Inc. Business Overview
  64. 7.11.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Portfolio
  66. 7.11.5 Catabasis Pharmaceuticals, Inc. Recent Developments
  67. 7.12 Cardero Therapeutics Inc
  68. 7.12.1 Cardero Therapeutics Inc Company Information
  69. 7.12.2 Cardero Therapeutics Inc Business Overview
  70. 7.12.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Product Portfolio
  72. 7.12.5 Cardero Therapeutics Inc Recent Developments
  73. 7.13 Biovista Inc.
  74. 7.13.1 Biovista Inc. Company Information
  75. 7.13.2 Biovista Inc. Business Overview
  76. 7.13.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Biovista Inc. Friedreich Ataxia Drug Product Portfolio
  78. 7.13.5 Biovista Inc. Recent Developments
  79. 7.14 BioMarin Pharmaceutical Inc.
  80. 7.14.1 BioMarin Pharmaceutical Inc. Company Information
  81. 7.14.2 BioMarin Pharmaceutical Inc. Business Overview
  82. 7.14.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Portfolio
  84. 7.14.5 BioMarin Pharmaceutical Inc. Recent Developments
  85. 7.15 Adverum Biotechnologies Inc
  86. 7.15.1 Adverum Biotechnologies Inc Company Information
  87. 7.15.2 Adverum Biotechnologies Inc Business Overview
  88. 7.15.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Portfolio
  90. 7.15.5 Adverum Biotechnologies Inc Recent Developments
8 North America
  1. 8.1 North America Friedreich Ataxia Drug Market Size by Type
  2. 8.1.1 North America Friedreich Ataxia Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Friedreich Ataxia Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Friedreich Ataxia Drug Price by Type (2021-2032)
  5. 8.2 North America Friedreich Ataxia Drug Market Size by Application
  6. 8.2.1 North America Friedreich Ataxia Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Friedreich Ataxia Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Friedreich Ataxia Drug Price by Application (2021-2032)
  9. 8.3 North America Friedreich Ataxia Drug Market Size by Country
  10. 8.3.1 North America Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Friedreich Ataxia Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Friedreich Ataxia Drug Market Size by Type
  2. 9.1.1 Europe Friedreich Ataxia Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Friedreich Ataxia Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Friedreich Ataxia Drug Price by Type (2021-2032)
  5. 9.2 Europe Friedreich Ataxia Drug Market Size by Application
  6. 9.2.1 Europe Friedreich Ataxia Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Friedreich Ataxia Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Friedreich Ataxia Drug Price by Application (2021-2032)
  9. 9.3 Europe Friedreich Ataxia Drug Market Size by Country
  10. 9.3.1 Europe Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Friedreich Ataxia Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Friedreich Ataxia Drug Market Size by Type
  2. 10.1.1 China Friedreich Ataxia Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Friedreich Ataxia Drug Sales by Type (2021-2032)
  4. 10.1.3 China Friedreich Ataxia Drug Price by Type (2021-2032)
  5. 10.2 China Friedreich Ataxia Drug Market Size by Application
  6. 10.2.1 China Friedreich Ataxia Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Friedreich Ataxia Drug Sales by Application (2021-2032)
  8. 10.2.3 China Friedreich Ataxia Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Friedreich Ataxia Drug Market Size by Type
  2. 11.1.1 Asia Friedreich Ataxia Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Friedreich Ataxia Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Friedreich Ataxia Drug Price by Type (2021-2032)
  5. 11.2 Asia Friedreich Ataxia Drug Market Size by Application
  6. 11.2.1 Asia Friedreich Ataxia Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Friedreich Ataxia Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Friedreich Ataxia Drug Price by Application (2021-2032)
  9. 11.3 Asia Friedreich Ataxia Drug Market Size by Country
  10. 11.3.1 Asia Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Friedreich Ataxia Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Friedreich Ataxia Drug Market Size by Type
  2. 12.1.1 SAMEA Friedreich Ataxia Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Friedreich Ataxia Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Friedreich Ataxia Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Friedreich Ataxia Drug Market Size by Application
  6. 12.2.1 SAMEA Friedreich Ataxia Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Friedreich Ataxia Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Friedreich Ataxia Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Friedreich Ataxia Drug Market Size by Country
  10. 12.3.1 SAMEA Friedreich Ataxia Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Friedreich Ataxia Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Friedreich Ataxia Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Friedreich Ataxia Drug Value Chain Analysis
  2. 13.1.1 Friedreich Ataxia Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Friedreich Ataxia Drug Production Mode & Process
  6. 13.2 Friedreich Ataxia Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Friedreich Ataxia Drug Distributors
  9. 13.2.3 Friedreich Ataxia Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst